Egypt implements precautionary plans after foot-and-mouth disease reported in several countries
The authority also decided to implement early warning activities and precautionary plans to protect livestock from epidemic and cross-border diseases, particularly foot-and-mouth disease and the SAT 1 strain.
The Minister of Agriculture received a detailed report from the Chairman of the Authority, Hamed al-Aqnas, in which he reviewed the authority's proactive plans, its central departments, and the Veterinary Medicine Directorates in the governorates to protect Egyptian livestock.
Strain reported across various countries
According to the report, confirmed cases of SAT1 strain infection have been detected in Iraq, Bahrain, Kuwait, and Turkey, according to reports issued by international reference laboratories and the website of the World Organization for Animal Health.
A genetic match was also observed between the isolated strains in this region and those endemic in some African countries, indicating an active epidemic path for this strain, which may be linked to the movement of animals or their products, or illegal movement across national borders – especially since the foot-and-mouth disease virus spreads rapidly.
Egypt's epidemiological situation is stable, Aqnas assured, adding that vaccines and serums are available with no issues.
This is in addition to the periodic national vaccination campaigns launched by the authority in all villages and hamlets across Egypt to protect livestock and support small farmers.
The state of alert has been raised in veterinary medicine directorates across the country, he added, with epidemiological surveillance teams monitoring any suspected cases or potential outbreaks, responding quickly, and collecting samples for laboratory testing from any suspected cases – especially in markets, border governorates, and high-risk areas identified using geographic information systems.
Edited translation from Al-Masry Al-Youm
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily News Egypt
a day ago
- Daily News Egypt
Egypt's PM reviews government complaints system responses
Egyptian Prime Minister Mostafa Madbouly has reviewed a report on the responses of the unified government complaints system to a number of cases in various sectors, his office said in a statement. Madbouly directed that complaints and appeals from citizens requiring urgent attention—such as those related to health, the protection of lives and property, and cases of special need—be given priority. The director of the complaints system, Dr. Tarek El-Refai, presented the report, which detailed the system's rapid response to several humanitarian cases in coordination with relevant ministries and governorates. In the area of protecting lives and property, the system responded to complaints about a diesel leak at a fuel station on the Suez-Port Said road, coordinating with the Ministry of Petroleum and civil defence to secure the area. It also addressed complaints about the 'June 30' axis road, with the Ministry of Transport and the National Roads Company carrying out maintenance and installing expansion joints. Additionally, fences on bridges on the Ring Road and in Rod El Farag were repaired. For medical appeals, the system facilitated treatment for a woman with morbid obesity after she appealed to the president. She was transported from Daqahliya to a university hospital in Cairo, where she underwent successful bariatric surgeries. The system also arranged for a young man with a spinal deformity to have successful corrective surgery at the state's expense. In a case of special need, a girl with a contagious skin disease in Daqahliya who had no shelter was transferred to a hospital for medical care so she could later be placed in a suitable care home. Regarding the maintenance of public utilities, the report highlighted the repair of a broken water pipe in Zamalek, Cairo; the repair of a broken sewage pipeline that had caused water cuts in several villages in Luxor; and the replacement of a burnt-out electricity distribution box in Giza. The system also responded to complaints about clearing waterways, including the Safat al-Awsat drain in Sharqia governorate, which serves 18,000 acres of agricultural land, and a blockage in a covered agricultural drain in Kafr El-Sheikh. In response to complaints about encroachments, the system coordinated with governorates to remove encroachments on state-owned land in Qena and agricultural land in Ismailia, and to shut down unlicensed shops and warehouses in Cairo. Finally, concerning market regulation and commodity availability, the system facilitated the provision of butane gas cylinders to villages in Beheira and Kafr El-Sheikh in coordination with the Ministry of Supply. It also took legal action against a farm in Sharqia for selling live meat for slaughter outside licensed abattoirs and for failing to adhere to health practices, in coordination with the National Food Safety Authority.
Daily News Egypt
a day ago
- Daily News Egypt
Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion
Triquera B.V., the majority shareholder of Egyptian biopharmaceutical leader Minapharm, has secured a minority investment from Admaius Capital Partners in a landmark deal aimed at accelerating the regional and global expansion of Minapharm's biotechnology footprint. Admaius, an Africa-focused private equity firm, joins forces with Triquera to support the continued growth of Minapharm, which operates one of the largest biological drug substance and product facilities in the Middle East and Africa. The company is renowned for its end-to-end capabilities in manufacturing complex recombinant proteins, viral vectors, and advanced biologics, with operations in both Cairo and Berlin. The strategic partnership is expected to fast-track the development and distribution of affordable, high-quality genetically engineered therapies across underserved markets in Africa and the Middle East. It will also focus on expanding Minapharm's licensing of proprietary technologies in monoclonal antibodies, cell and gene therapies, and vaccines—many of which have been incorporated into FDA-approved products. The collaboration includes plans to explore strategic acquisitions of global contract development and manufacturing organizations (CDMOs), further positioning Minapharm as a competitive force in the global biotech industry. Strategic Alignment and Regional Impact Dr. Wafik Bardissi, Chairman and CEO of Minapharm, welcomed the partnership, stating: 'With Admaius, we gain not only capital but a strategic partner whose insight, alignment, and ambition match our own. Together, we are advancing regional self-sufficiency and expanding the global reach of our innovations.' Admaius Capital Partners Managing Partner Marlon Chigwende described the deal as a 'landmark transaction,' adding: 'The founding families have built a unique asset on the African and European continents that combines scale, growth, and impact to fight cancer and other awful diseases.' Ahmed Rady, Managing Director at Admaius, praised the Minapharm team's scientific and operational capabilities: 'This partnership is about scaling a homegrown champion that combines cutting-edge global know-how with end-to-end manufacturing excellence.' Dr. Shaheer Bardissi, Co-CEO of Minapharm, emphasized the broader industry implications of the deal: 'This strategic collaboration with Admaius will accelerate and scale Minapharm's vision of translating cutting-edge scientific innovation into affordable therapies, while advancing global scientific frontiers in immunotherapy and advanced therapy medicinal products.' Advisory Teams Zilla Capital acted as the sole financial advisor to Triquera and existing shareholders, while legal counsel was provided by Matouk Bassiouny. Admaius Capital Partners was advised by White & Case LLP and commercial consultant Arthur D. Little.
Daily News Egypt
2 days ago
- Daily News Egypt
Egypt, Novartis explore expanding collaboration in oncology, cardiology
Ahmed El-Sobky, Chairperson of Egypt's General Authority for Healthcare and supervisor of the Universal Health Insurance Project, met on Sunday with Gehan El-Emary, Chairperson and Managing Director of Novartis Egypt, to follow up on the progress of a memorandum of understanding (MoU) signed in February. The MoU, which aims to enhance cancer care, broaden cardiology collaboration, and promote medical training, has seen significant developments, according to an official statement from the Authority. El-Sobky highlighted the authority's goal to transform the Aswan Oncology Center into a leading regional and research hub for cancer treatment, with the involvement of international partners, including Novartis. During the meeting, El-Sobky extended a formal invitation to Novartis officials to visit the center and explore potential areas for further collaboration on-site. The meeting also focused on efforts to modernize clinical protocols for heart disease and breast cancer, alongside expanding training programs for healthcare providers in line with global best practices. El-Sobky emphasized the importance of increasing the number of physicians benefiting from these programs in partnership with Novartis to strengthen healthcare delivery across Egypt. In addition, the two sides discussed the possibility of launching a certified digital training platform designed to equip family doctors with the tools and skills necessary to manage non-communicable diseases such as hypertension, diabetes, and chronic heart conditions. They also explored innovative strategies to raise public health awareness and ensure continuity of care in underserved areas. Gehan El-Emary expressed pride in the growing partnership between Novartis and the General Authority for Healthcare, noting the tangible successes achieved through their joint initiatives. She reaffirmed Novartis's ongoing commitment to expanding its collaboration with the Authority, particularly in the areas of early detection, cancer care, cardiology, and chronic disease management.
